Anorexia and malnutrition in patients with obstructive jaundice

Nutrition

Volumn 18, Issue 11-12, 2002, Pages 987-990

  Padillo, F J ^a   Andicoberry, B ^a   Pera Madrazo, C ^a   Sitges Serra, A ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; LEPTIN; SECRETIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ANOREXIA; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILE FLOW; BILIARY TRACT DRAINAGE; CLINICAL FEATURE; DIETARY INTAKE; DISEASE COURSE; FOOD INTAKE; HUMAN; LIVER FUNCTION; NEGATIVE FEEDBACK; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OBSTRUCTIVE JAUNDICE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN CALORIE MALNUTRITION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036846198     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)00982-6     Document Type: Article

References (58)

1. Ishida Y., Nagao T., Uchida H. Nutritional and immunological assessment in patients with malignant obstructive jaundice - the influence of preoperative biliary decompression and abdominal surgery. Nippon Geka Gakkai Zasshi. 95:1994;71.
2. Sherlock S. Diseases of the liver and biliary system. 1989;Blackwell Scientific Publications, Boston. 248.
3. Rege R.V. Adverse effects of biliary obstruction implications for treatment of patients with obstructive jaundice . AJR. 164:1995;287.
4. Padillo F.J., Canis M., Rufián S., et al. The palliative treatment of pancreatic cancer percutaneous drainage versus surgical diversion . Rev Esp Enf Digest. 81:1992;337.
5. Mullen J.L., Buzby G.P., Mattews D.C. Reduction of operative morbidity and mortality by combined preoperative and postoperative nutritional support. Ann Surg. 192:1981;604.
6. Buzby G.P., Williford W.O., Peterson O. A randomized clinical trial of TPN in malnourished surgical patients the rationale and impact of previous clinical trials and pilot study on the protocol design . Am J Clin Nutr. 47:1988;357.
7. Padillo F.J., Rodriguez M., Hervas A., et al. Nutritional assessment of patients with benign and malignant obstructions of the biliary tract. Rev Esp Enferm Dig. 91:1999;622.
8. Padillo F.J., Andicoberry B., Muntané J., et al. Factors predicting nutritional derangements in patients with obstructive jaundice a multivariate analysis . World J Surg. 25:2001;67.
9. Chang R.W.S. Nutritional assessment using a microcomputer. 1. Programme design. Clin Nutr. 3:1984;67.
10. Ballinger A.B., McHugh M., Catnach S.M., Alstead E.M., Clark M.L. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 35:1994;467.
11. Andicoberry B., Padillo F.J., Gómez-Alvarez M., et al. Evaluation of anorexia in patients with bile duct obstruction. Nutr Hosp. 14:1999;38.
12. Padillo F.J., Andicoberry B., Naranjo A., et al. Anorexia and the effect of internal biliary drainage on food intake in patients with obstructive jaundice. J Am Coll Surg. 192:2001;584.
13. Valverde J., Martínez-Ródenas F., Pereira J.A., et al. Rapid increase in plasma levels of atrial natriuretic peptide after common bile duct ligation in the rabbit. Ann Surg. 216:1992;554.
14. Sitges-Serra A., Franch G. Nutrition assessment. Payne-James J., Grimble G., Silk D., Artificial Nutritional Support in Clinical Practice. 1995;Edward Arnold, Sevenoaks, UK.
15. Frisancho A.R. Triceps skinfold and upper arm size norms for assessment of nutritional status. Am J Clin Nutr. 27:1974;1052.
16. Durning J.V.G.A., Rahaman M.M. The assessment of the amount of fat in the human body measurements of skinfold thickness. Br J Nutr. 21:1967;681.
17. Young G.A., Hill G.L. Assessment of protein calorie malnutrition in surgical patients from plasma proteins and anthropometric measurements. Am J Clin Nutr. 31:1972;429.
18. Jensen T.G., Englert D.M., Dudrick S.J. Nutritional assessment: a manual for practitioners. 1983;Appleton-Century-Crofts, Norwalk, CT.
19. Tuten M.B., Wogt S., Dasse F., Leider Z. Utilization of prealbumin as a nutritional parameter. JPEN. 9:1983;709.
20. Dempsey D.T., Mullen J.L., Buzby G.P. The link between nutritional status and clinical outcome can nutritional intervention modify it? Am J Clin Nutr. 47:1988;352.
21. Sitges-Serra A., Carulla X., Piera C., et al. Body water compartments in patients with obstructive jaundice. Br J Surg. 79:1992;553.
22. Gallardo J.M., Padillo F.J., Martín-Malo A., et al. Increased plasma levels of atrial natriuretic peptide and endocrine markers of volume depletion in patients with obstructive jaundice. Br J Surg. 85:1998;28.
23. Padillo F.J., Rodríguez M., Gallardo J.M., et al. Preoperative assessment of body fluid disturbances in patients with obstructive jaundice. World J Surg. 23:1999;681.
24. Mullen J.L., Gertner M.H., Buzby G.P., Goodhart S.L., Rosato E.F. Implications of malnutrition in the surgical patients. Arch Surg. 114:1979;121.
25. Inoue Y., Okada A., Nezu R. Rapid turnover protein as index of nutritional status in benign diseases. Nutrition. 7:1990;45.
26. Grant J.P., Custer P.B., Thurloiw J. Current techniques of nutritional assessment. Surg Clin North Am. 61:1981;437.
27. Kowalski-Saunders P.W.J., Winwood P.J., Arthur M.J.P., Wright R. Reversible inhibition of albumin production by rat hepatocytes maintained in a laminin-rich gel (Engdbroh-Holm-Susarm) in response to secretory products of Kupffer cells and cytokines. Hepatology. 16:1992;733.
28. Falconer J.S., Fearon K.C.H., Plester C.E., Ross J.A., Carter D.C. Cytokines, the acute-phase response and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 219:1994;325.
29. Fearon K.C.H., Falconer J.S., Slater C., et al. Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg. 227:1998;249.
30. Santi G., Ilyin S.E., Plata-Salaman C.R. Anorexia induced by cytokine interaction at pathophysiological concentrations. Am J Physiol. 270:1996;1394.
31. Plata-Salaman C.R. Anorexia induced by activators of the signal transducer gp130. Neuroreport. 7:1996;841.
32. Sanaf P., Frederich R.C., Turner E.M., et al. Multiple cytokines and acute inflammation raise mouse leptin levels potential role in inflammatory anorexia . J Exp Med. 185:1997;171.
33. Puntis M.C., Jiang W.G. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice. J Gastroenterol Hepatol. 11:1996;7.
34. Padillo F.J., Andicoberry B., Muntané J., et al. Cytokines and acute-phase response markers derangements in patients with obstructive jaundice. Hepatogastroenterology. 48:2001;378.
35. DeWys W.D., Eastern Co-operative Oncology Group . Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 69:1980;491.
36. Espat N.J., Lopeland E.M., Moldawer L.L. Tumor necrosis factor and cachexia a current perspective . Surg Oncol. 3:1994;255.
37. Tompkins R.G. The role of proinflammatory cytokines in inflammatory metabolic responses. Ann Surg. 225:1997;243.
38. Koop J., Koop H., Gerhardt C., Schafmayer A., Arnold R. Do bile acids exert a negative feedback control of cholecystokinin release? Scand J Gastroenterol. 24:1989;315.
39. Koop I. Role of bile acids in the control of pancreatic secretion and CCK release. Eur J Clin Invest. 20:1990;51.
40. Schmidt W.E., Creutzfeldt W., Hocker M., et al. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Eur J Clin Invest. 21:1991;501.
41. Nakamura R., Miyasaka K., Kuyama Y., Kitami K. Luminal bile regulates cholecystokinin release in conscious rats. Dig Dis Sci. 35:1990;55.
42. Izukura M., Hashimoto T., Gomez G., et al. Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs. Pancreas. 6:1991;427.
43. Hildebrand P., Petrig C., Burckhardt B., et al. Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology. 114:1998;123.
44. Thimister P.W.L., Hopman W.P.M., Sloots C.E.J., et al. Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids. Gastroenterology. 110:1996;567.
45. Reidelberger R.D., Varga G., Liehr R.M., et al. Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats. Am J Physiol. 267:1994;901.
46. Zittel T.T., von Elm B., Teichmann R.K., Rabould H.E., Becker H.D. Cholecystokinin is partly responsible for reduced food intake and body weight loss after total gastrectomy in rats. Am J Surg. 169:1995;265.
47. Crawley J.N., Kiss J. Paraventricular nucleus lesions abolish the inhibition of feeding induced by systematic cholecystokinin. Peptides. 6:1985;927.
48. Higham A., Vaillant C., Yegen B., Thompson D.G., Dockray G.J. Relation between cholecystokinin and antral innervation in the control of gastric emptying in the rat. Gut. 41:1997;24.
49. Tangoku A., Doi R., Chowdhury P., et al. Use of a specific cholecystokinin receptor antagonist (L-364,718) to determine the role of cholecystokinin on feeding and body weight in rats with obstructive jaundice. J Assoc Acad Minor Phys. 2:1992;38.
50. Cowley M.A., Smart J.L., Rubinstein M., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:2001;480.
51. Rioux K.P., Beck P.L., Hoppin A.G., et al. Differential leptin responses to acute and chronic biliary obstruction in rats. J Hepatol. 33:2000;19.
52. Muntane-Relat J., Ourlin J.C., Domergue J., Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2 and CYP3A4 in human hepatocytes in primary culture. Hepatology. 22:1995;1143.
53. Herrera J.L. Abnormal liver enzyme levels. The spectrum of causes. Postgrad Med J. 93:1993;113.
54. McPherson G.A.D., Benjamin L.S., Habib N.A., Bowley N.B., Blumgart L.H. Percutaneous transhepatic drainage in obstructive jaundice advantages and problems . Br J Surg. 69:1982;261.
55. Pitt H.A., Gomes A.S., Lois J.F., et al. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg. 201:1985;545.
56. Padillo F.J., Gallardo J.M., Naranjo A., et al. Changes in the pattern of visceral proteins after internal biliary drainage in patients with obstructive jaundice. Eur J Surg. 165:1999;550.
57. Denning D.A., Ellison E.C., Carey L.E. Preoperative percutaneous transhepatic biliary decompression lowers operative morbidity in patients with obstructive jaundice. Am J Surg. 141:1981;61.
58. Norlander A., Kalin B., Sundblad R. Effect of percutaneous transhepatic drainage upon liver function and postoperative mortality. Surg Gynecol Obstet. 155:1982;161.